BioLineRx (BLRX) Net Cash Flow Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | -433.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -433.03% |
| Sep 30, 2025 | 175.00% |
| Jun 30, 2025 | -158.36% |
| Mar 31, 2025 | -178.27% |
| Dec 31, 2024 | 139.25% |
| Sep 30, 2024 | 62.34% |
| Jun 30, 2024 | 204.13% |
| Mar 31, 2024 | 218.34% |
| Dec 31, 2023 | -48.46% |
| Sep 30, 2023 | -156.11% |
| Jun 30, 2023 | -57.94% |
| Mar 31, 2023 | 3.92% |
| Dec 31, 2022 | -85.42% |
| Sep 30, 2022 | 73.51% |
| Jun 30, 2022 | 141.53% |
| Mar 31, 2022 | -154.03% |
| Dec 31, 2021 | -113.23% |
| Sep 30, 2021 | -432.16% |
| Jun 30, 2021 | 210.57% |
| Mar 31, 2021 | -264.38% |
| Dec 31, 2020 | 2,749.29% |
| Sep 30, 2020 | 1,102.94% |
| Jun 30, 2020 | -26.27% |
| Mar 31, 2020 | -116.29% |
| Dec 31, 2019 | 127.07% |
| Sep 30, 2019 | 86.72% |
| Jun 30, 2019 | 125.73% |
| Mar 31, 2019 | -63.32% |
| Dec 31, 2018 | 24.62% |
| Sep 30, 2018 | -137.77% |
| Jun 30, 2018 | -146.42% |
| Mar 31, 2018 | 839.50% |
| Dec 31, 2017 | -12.63% |
| Sep 30, 2017 | -371.43% |
| Jun 30, 2017 | 715.31% |
| Mar 31, 2017 | 62.21% |
| Dec 31, 2016 | -1,576.92% |
| Sep 30, 2016 | 102.97% |
| Jun 30, 2016 | -157.55% |
| Mar 31, 2016 | -141.26% |
| Dec 31, 2015 | -90.89% |
| Sep 30, 2015 | -18.15% |
| Jun 30, 2015 | 273.08% |
| Mar 31, 2015 | 1,324.54% |
| Dec 31, 2014 | 136.15% |
| Sep 30, 2014 | -76.77% |
| Jun 30, 2014 | -171.27% |
| Mar 31, 2014 | 102.83% |